Jason Mehring
Analyst · Raymond James
Thank you, Alex, and thank you to our investors and analysts for joining us today. Today, I'll discuss the highlights of our third quarter 2026 performance. Then Dan Worrell, our President, will cover our portfolio and investment activity; and Erik Cuellar, our CFO, will walk through our financial results, balance sheet and liquidity. With that, let me turn to our third quarter results. As a reminder, during the quarter, we completed the sale of approximately $524 million of investments to a continuation vehicle sponsored by Pantheon. The continuation vehicle also assumed the $405 million of CLO debt that had been issued during the second quarter of 2026. In addition, we announced that our Board had engaged Keefe, Bruyette & Woods to assist with the review of strategic alternatives. While we do not yet have a definitive outcome of the review to share today, we continue to make progress and remain focused on reaching the best possible outcome for our shareholders. We will provide additional information at the appropriate time. Looking at our third quarter performance, in addition to the investments sold as part of the continuation vehicle transaction, we saw repayment and realization activity totaling $224 million. As we noted in our last call, this included the full payoffs of our investments in Motive Technologies and Pico shortly after the end of the second quarter. It also included the full repayment of our investments in ESO Solutions and Domo following its sale. These repayments increased our liquidity, reduced net leverage to 0.16x and contributed to a quarter end cash balance of approximately $253 million. Given the ongoing strategic review, we made a deliberate decision to maximize investment dry powder and liquidity rather than pursue new deployment opportunities. While we do not intend to hold this level of cash over the long term, following discussions with our adviser, we believe this approach best preserves optionality to maximize shareholder value and keeps all alternatives available to the Board as it continues the evaluation process. Moving to the portfolio. NAV declined $0.97 per share from $6.58 to $5.61 per share at September 30. The primary driver was the $0.68 per share impact of the portfolio sale transaction, which we discussed on our last call. The largest component of the remaining reduction was attributable to Job & Talent, which accounted for $0.15 per share of the decline. Job & Talent is currently evaluating strategic alternatives and our quarter end valuation reflects the latest information available from that process. Other markdowns in the portfolio in aggregate reduced NAV by approximately $0.13 per share. Nonaccruals as a percentage of portfolio value increased during the quarter, reflecting both new nonaccruals and significant repayment activity that reduced the size of the portfolio. Dan will provide more details later. Turning to capital allocation. On November 5, 2026, our Board of Directors declared a fourth quarter dividend of $0.17 per share payable on December 31, 2026, to shareholders of record as of December 17, 2026. With a smaller portfolio and elevated cash balances, adjusted net investment income was $0.15 per share for the quarter compared with a $0.17 per share dividend in the third quarter. The Board will continue to evaluate the dividend in the context of the strategic review. With that, I'll turn the call over to our President, Dan Worrell, to discuss the portfolio and investment activity.